Nuclear magnetic resonance spectroscopy, most commonly known as NMR spectroscopy or magnetic resonance spectroscopy (MRS), is a spectroscopic technique that is used to observe local magnetic fields around atomic nuclei. Over the past fifty years, NMR spectroscopy has become the leading technique for determining the structure of organic compounds. Of the spectroscopic methods, it is the only one, for which a complete analysis and interpretation of the entire spectrum is normally expected.

• This has also been found to be non-destructive and is analyzed with the help of modern instruments. Good data may be obtained from samples weighing less than a milligram.
• NMR spectroscopy accounts for a bigger share in the molecular spectroscopy market, due to its wide usage in application areas, like pharmaceuticals, biotechnology and biopharmaceuticals, food and beverage testing, environmental testing, and in research institutes. 
• NMR techniques are also being used successfully in various food systems for quality control and research.
• NMR spectroscopy is used to determine the structure of proteins, amino acids profile, carotenoids, organic acids, lipid fractions, and the mobility of the water in foods. It is also used to identify and quantify metabolites in foods.
• In addition, the NMR spectroscopy is increasingly being used in biochemical and biological application areas, including hit and lead discovery, metabolite profiling, and in vivo spectroscopy (MRS) and imaging (MRI). Thus, this highlights the key areas in this rich array of pharmaceutical applications of NMR spectroscopy. 
• The many new developments seen in the NMR spectroscopy are driving much-needed improvements in sensitivity and versatility.
• This will lead to the expansion of the number of applications of the technique, and hence, growth in the market studied.

• The increasing R&D and funding are driving the market studied in the United Kingdom. 
• The UK researchers investigating materials and molecular structures may be able to take advantage of new and highly precise scientific instrumentation, operating in eight UK universities, with a EUR 20 million investment in NMR equipment.
•  This investment on very-high and ultra-high field Nuclear Magnetic Resonance (NMR) spectroscopy was announced by the EPSRC on behalf of three other research councils, the Biotechnology and Biosciences Research Council (BBSRC), Medical Research Council (MRC), and Natural Environment Research Council (NERC), which have supported the funding and also forms part of UK Research and Innovation (UKRI), a non-departmental public body funded by a grant-in-aid from the UK government.
• It has also been found that the United Kingdom has also currently fallen behind the rapid Dynamic nuclear polarization (DNP) NMR spectroscopy developments that have taken place in other European countries, in terms of developing the applications.
• The proposed 600 MHz DNP MAS NMR facility, which may cost around approximately EUR 2.1 million, would enable UK users to develop their own application portfolio tailored to the specific requirements of DNP NMR.